Carregant...
The Role of PI3K in Met Driven Cancer: A Recap
The Receptor Tyrosine Kinase (RTK) Met, overexpressed or mutated in cancer, plays a major role in cancer progression and represents an attractive target for cancer therapy. However RTK inhibitors can lead to drug resistance, explaining the necessity to develop therapies that target downstream signal...
Guardat en:
| Publicat a: | Front Mol Biosci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207648/ https://ncbi.nlm.nih.gov/pubmed/30406111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2018.00086 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|